Study: MRSA Nasal Swab Testing Not Compromised by Mupirocin

Why It Matters

Accurate MRSA screening after decolonization enables targeted therapy, improving patient safety and supporting antimicrobial stewardship. It also helps hospitals avoid unnecessary broad‑spectrum antibiotics and associated costs.

Key Takeaways

• Study of 1,034 ICU patients across four Tennessee hospitals.
• NPV 99.1% within 7 days of mupirocin, non‑inferior.
• Findings support safe MRSA test‑guided antibiotic de‑escalation.
• Results may vary with regional MRSA prevalence or resistance.
• Not applicable to povidone‑iodine or alcohol decolonization.

Pulse Analysis

Methicillin‑resistant Staphylococcus aureus (MRSA) remains a leading cause of hospital‑acquired infections, prompting widespread use of nasal PCR screening to identify carriers. Clinicians often apply mupirocin ointment in intensive care units to eradicate nasal colonization, but concerns linger that the antibiotic could suppress bacterial DNA and skew PCR results. Understanding whether decolonization interferes with test performance is critical for maintaining reliable infection‑control metrics and for making informed decisions about empiric therapy.

The Vanderbilt‑led study examined 1,034 adult inpatients, splitting them almost evenly between pre‑ and post‑mupirocin testing groups. Within the first week after ointment application, the PCR assay’s negative predictive value rose slightly to 99.1%, comfortably within the pre‑specified 2% non‑inferiority threshold. Specificity and NPV remained high beyond seven days, though the small number of subsequent MRSA infections limited statistical certainty. These findings demonstrate that the molecular assay detects residual bacterial DNA even when viable organisms are suppressed, preserving diagnostic fidelity and allowing clinicians to confidently de‑escalate anti‑MRSA agents such as vancomycin.

For hospitals, the practical impact is twofold: reduced reliance on broad‑spectrum antibiotics and streamlined stewardship workflows. By confirming that mupirocin does not compromise PCR accuracy, infection‑control teams can maintain aggressive decolonization protocols without fearing diagnostic blind spots. However, the study’s regional focus and exclusion of alternative decolonization methods mean results may not translate universally. Future research should explore diverse geographic settings and compare mupirocin with povidone‑iodine or alcohol‑based regimens to fully map the interplay between decolonization strategies and molecular diagnostics.